Altmetric – Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial)

Title	Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial)
Published in	Trials, December 2019
DOI	10.1186/s13063-019-3856-8
Pubmed ID	31842993
Authors	Pascal Urwyler, Maria Boesing, Kristin Abig, Marco Cattaneo, Thomas Dieterle, Andreas Zeller, Herbert Bachler, Stefan Markun, Oliver Senn, Christoph Merlo, Stefan Essig, Elke Ullmer, Jonas Rutishauser, Macé M Schuurmans, Joerg Daniel Leuppi

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
Austria	1	50%
Unknown	1	50%

Type	Count	As %
Scientists	1	50%
Members of the public	1	50%

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	34	100%

Readers by professional status	Count	As %
Student > Master	7	21%
Researcher	5	15%
Other	3	9%
Student > Bachelor	2	6%
Student > Ph. D. Student	2	6%
Other	3	9%
Unknown	12	35%

Readers by discipline	Count	As %
Medicine and Dentistry	11	32%
Nursing and Health Professions	8	24%
Pharmacology, Toxicology and Pharmaceutical Science	2	6%
Mathematics	1	3%
Unknown	12	35%

Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial)